Project cooperationUpdated on 28 April 2026
Co-develop novel biologics
About
NanoVet is seeking project-based collaborations to co-develop novel biologics targeting major unmet needs in companion animal health, particularly in dermatology, oncology, and chronic inflammatory diseases. We are interested in partnering to advance existing programs into clinical development, explore new targets, or combine our nanobody platform with complementary technologies, such as delivery systems or formulation innovations.
Similar opportunities
Partnership
With Animal Health and Biotech companies
Nicolás Galmarini
CEO & Co-founder at NanoVet Biotech
Pamplona, Spain
Investment
Accelerate preclinical and clinical development
Nicolás Galmarini
CEO & Co-founder at NanoVet Biotech
Pamplona, Spain